Back to top

Top Ranked Momentum Stocks to Buy for September 6th

Read MoreHide Full Article

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 6th:

Ligand Pharmaceuticals Incorporated (LGND - Free Report) : This biopharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 14.4% over the last 60 days.

Ligand Pharmaceuticals Incorporated Price and Consensus

Ligand’s shares gained 3% over the last one month more than S&P 500’s gain of 1.1%. The company possesses a Momentum Score of A.

Ligand Pharmaceuticals Incorporated Price

Sesen Bio, Inc. (SESN - Free Report) : This late-stage clinical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 18.8% over the last 60 days.

Eleven Biotherapeutics, Inc. Price and Consensus

Sesen Bio’s shares gained 43.1% over the last one month. The company possesses a Momentum Score of B.

Eleven Biotherapeutics, Inc. Price

Interface, Inc. (TILE - Free Report) : This modular flooring company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 1.4% over the last 60 days.

Interface, Inc. Price and Consensus

Interface’s shares gained 6.2% over the last one month. The company possesses a Momentum Score of A.

Interface, Inc. Price

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Interface, Inc. (TILE) - free report >>

Eleven Biotherapeutics, Inc. (SESN) - free report >>

Ligand Pharmaceuticals Incorporated (LGND) - free report >>

More from Zacks Zacks #1 Rank Additions

You May Like